Palatin Technologies
PTN
#10515
Rank
โ‚ฌ17.87 M
Marketcap
10,04ย โ‚ฌ
Share price
9.37%
Change (1 day)
12,988.26%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚ฌ4.7 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ8.84 Million. In 2024 the company made an earning of -โ‚ฌ23.66 Million, an increase over its 2023 earnings that were of -โ‚ฌ28.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ4.7 Million-80.17%
2024 -โ‚ฌ23.66 Million-16.9%
2023 -โ‚ฌ28.47 Million5.99%
2022 -โ‚ฌ26.86 Million-13.7%
2021 -โ‚ฌ31.12 Million33.25%
2020 -โ‚ฌ23.36 Million-172.11%
2019 โ‚ฌ32.38 M2352.33%
2018 โ‚ฌ1.32 M-94.13%
2017 โ‚ฌ22.5 M-154.92%
2016 -โ‚ฌ40.97 Million3.67%
2015 -โ‚ฌ39.52 Million878%
2014 -โ‚ฌ4.05 Million-72.64%
2013 -โ‚ฌ14.77 Million-33.11%
2012 -โ‚ฌ22.08 Million77.71%
2011 -โ‚ฌ12.43 Million
2003 -โ‚ฌ21.04 Million29.93%
2002 -โ‚ฌ16.2 Million36.18%
2001 -โ‚ฌ11.9 Million
1999 -โ‚ฌ9.87 Million6.04%
1998 -โ‚ฌ9.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.80 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.87 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.70 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚ฌ10.55 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.14 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ84.1 M-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ25.89 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ50.88 Million 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA